Comparison of the effects of selective endothelin ETA and ETB receptor antagonists in congestive heart failure

Journal of the American College of Cardiology

Volumn 30, Issue 5, 1997, Pages 1385-1392

  Wada, Atsuyuki ^a   Tsutamoto, Takayoshi ^a   Fukai, Daisuke ^a   Ohnishi, Masato ^a   Maeda, Keiko ^a   Hisanaga, Tomoko ^a   Maeda, Yukiharu ^a   Matsuda, Yuzuru ^b   Kinoshita, Masahiko ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b KYOWA HAKKO KOGYO CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 [[2 [[2 [[(HEXAHYDRO 1H AZEPIN 1 YL)CARBONYL]AMINO] 4 METHYLPENTANOYL]AMINO] 3 (1 METHYL 1H INDOL 3 YL)PROPIONYL]AMINO] 3 (2 PYRIDYL)PROPIONIC ACID; ALDOSTERONE; ATRIAL NATRIURETIC FACTOR; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR; ENDOTHELIN B RECEPTOR ANTAGONIST; ENDOTHELIN RECEPTOR; NORADRENALIN; RES 701 1; SODIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DOG; DRUG EFFECT; FEMALE; GLOMERULUS FILTRATION RATE; HEART VENTRICLE PACING; HEART VENTRICLE PRESSURE; KIDNEY PLASMA FLOW; MALE; NATRIURESIS; NONHUMAN; PRIORITY JOURNAL; URINE FLOW RATE;

ANALYSIS OF VARIANCE; ANIMALS; ATRIAL NATRIURETIC FACTOR; AZEPINES; CARDIAC OUTPUT; DOGS; FEMALE; HEART; HEART FAILURE, CONGESTIVE; HEMODYNAMIC PROCESSES; INDOLES; KIDNEY; MALE; PEPTIDES, CYCLIC; RECEPTORS, ENDOTHELIN; URODYNAMICS;

EID: 0030859682     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(97)00296-9     Document Type: Article

References (34)

1. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 332:1988;411-415.
2. Inoue A, Yanagisawa M, Kimura S, et al. The human endothelin family three structurally and pharmacologically distinct isopeptides predicted by three separate genes . Proc Natl Acad Sci U S A. 86:1989;2863-2867.
3. Arai H, Hori S, Aramori I, Ohkubo H, Nakanishi S. Cloning and expression of a cDNA encoding an endothelin receptor. Nature. 348:1990;730-732.
4. Sakurai T, Yanagisawa M, Takuwa Y, et al. Cloning of cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature. 348:1990;732-734.
5. DeNucci G, Thomas R, D'Orleans-Juste P, et al. Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci U S A. 85:1988;9797-9800.
6. Miller WL, Redfield MM, Burnett JC Jr. Integrated cardiac, renal, and endocrine actions of endothelin. J Clin Invest. 83:1989;317-320.
7. Cavero PG, Miller WL, Heublein DM, Margulies KB, Burnett JC Jr. Endothelin in experimental congestive heart failure in the anesthetized dog. Am J Physiol. 259:1990;F312-F317.
8. Tsutamoto T, Wada A, Maeda Y, Adachi T, Kinoshita M. Relationship between endothelin-1 spillover in the lungs and the pulmonary vascular resistance in patients with chronic heart failure. J Am Coll Cardiol. 23:1994;1427-1433.
9. Seo B, Oemar BS, Siebenmann R, Segesser LV, Lüscher TF. Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels. Circulation. 89:1994;1203-1208.
10. Sakai S, Miyauchi T, Sakurai T, et al. Endogenous endothelin-1 participates in the maintenance of cardiac function in rats with congestive heart failure marked increase in endothelin-1 production in the failing heart . Circulation. 93:1996;1214-1222.
11. Shimoyama H, Sabbah HN, Borzak S, et al. Short-term hemodynamic effects of endothelin receptor blockade in dogs with chronic heart failure. Circulation. 94:1996;779-784.
12. The SOLV, Investigators D. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection. N Engl J Med. 327:1992;685-691.
13. Sogabe K, Nirei H, Shoubo M, et al. Pharmacological profile of FR139317, a novel, potent endothelin ETA receptor antagonist. J Pharmacol Exp Ther. 264:1992;1040-1046.
14. Tanaka T, Tsukuda E, Nozawa M, et al. RES-701-1, a novel, potent, endothelin type B receptor-selective antagonist of microbial origin. Mol Pharmacol. 45:1994;724-730.
15. Wada A, Tsutamoto T, Matsuda Y, Kinoshita M. Cardiorenal and neurohumoral effects of endogenous atrial natriuretic peptides in dogs with severe congestive heart failure using a specific antagonist for guanylate cyclase coupled receptor. Circulation. 89:1994;2232-2240.
16. Aramori I, Nirei H, Shoubo M, et al. Subtype selectivity of a novel endothelin antagonist, FR139317, for the two endothelin receptors in transfected Chinese hamster ovary cells. Mol Pharmacol. 43:1993;127-131.
17. Karaki H, Sudjarwo SA, Hori M, Tanaka T, Matsuda Y. Endothelin ETB receptor antagonist, RES-701-1 effects on isolated blood vessels and small intestine . Eur J Pharmacol. 262:1994;255-259.
18. Wada A, Tsutamoto T, Maeda Y, Kanamori T, Matsuda Y, Kinoshita M. Endogenous atrial natriuretic peptide inhibits endothelin-1 secretion in dogs with severe congestive heart failure. Am J Physiol. 270:1996;H1819-H1824.
19. Tsutamoto T, Bito K, Kinoshita M. Plasma atrial natriuretic polypeptide as an index of left ventricular end-diastolic pressure in patients with chronic left-sided heart failure. Am Heart J. 117:1989;599-606.
20. Kasai H, Takanashi M, Takasaki C, Endoh M. Pharmacological properties of endothelin receptor subtypes mediating positive inotropic effects in rabbit heart. Am J Physiol. 266:1994;H2220-H2228.
21. Fukuroda T, Fujikawa T, Ozaki S, Ishikawa K, Yano M, Nishikibe M. Clearance of circulating endothelin-1 by ETB receptors in rats. Biochem Biophys Res Commun. 193:1994;1461-1465.
22. Ozaki S, Ohwaki K, Ihara T, Fukuroda T, Ishikawa K, Yano M. ETB-mediated regulation of extracellular levels of endothelin-1 in cultured human endothelial cells. Biochem Biophys Res Commun. 209:1995;483-489.
23. Thibault G, Doubell AF, Garcia R, Lariviere R, Schiffrin EL. Endothelin-stimulated secretion of natriuretic peptides by rat atrial myocytes is mediated by endothelin A receptors. Circ Res. 74:1994;460-470.
24. Tsutamoto T, Wada A, Maeda K, et al. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction . Circulation. 96:1997;509-516.
25. Cozza EN, Gomez-Sanchez CE, Foecking MF, Chiou S. Endothelin binding to cultured calf adrenal zona glomerulosa cells and stimulation of aldosterone secretion. J Clin Invest. 84:1989;1032-1035.
26. Belloni AS, Rossi GP, Andreis PG, et al. Endothelin adrenocortical secretagogue effect is mediated by the B receptor in rats. Hypertension. 27:1996;1153-1159.
27. +-ATPase in intact renal tubular epithelial cells. Am J Physiol. 257:1989;C1101-C1107.
28. Tomita K, Nonoguchi H, Marumo F. Effects of endothelin on peptide-dependent cyclic adenosine monophosphate accumulation along the nephron segments of the rat. J Clin Invest. 85:1990;2014-2018.
29. King AJ, Brenner BM, Anderson S. Endothelin a potent renal and systemic vasoconstrictor peptide . Am J Physiol. 256:1989;F1051-F1058.
30. Uzuner K, Banks RO. Endothelin-induced natriuresis and diuresis are pressure-dependent events in the rats. Am J Physiol. 265:1993;R90-R96.
31. G-nitro-L-arginine methyl ester on renal function and blood pressure. Am J Physiol. 261:1991;F1033-F1037.
32. Carmines PK, Bell PD, Roman RJ, Work J, Navar LG. Prostaglandins in the sodium excretory response to altered renal arterial pressure in dogs. Am J Physiol. 248:1985;F8-14.
33. Brooks DP, DePalma PD, Pullen M, Nambi P. Characterization of canine renal endothelin receptor subtypes and their function. J Pharmacol Exp Ther. 268:1994;1091-1097.
34. Travill C, Williams T, Pate P, et al. Haemodynamic and neurohumoral response in heart failure produced by rapid ventricular pacing. Cardiovasc Res. 26:1992;783-790.